Anna Capovilla is a highly experienced professional in the life sciences and biotechnology sectors, currently serving as CEO of Genmark, a member of the Roche group. With a strong background in strategic roles, Anna has held positions such as Life Cycle Leader and VP of Sequencing at Roche, as well as Associate Vice President of Enterprise Strategy and Corporate Strategy at Agilent Technologies. Previous experience includes significant leadership roles at Illumina, where Anna managed product strategies for various portfolios, and various positions at Roche, including Director of International Business for Prenatal Testing. Anna has also contributed as an advisor for Harmonix and Neue Fund, focusing on technology investments aimed at social impact. Educational qualifications include a BSc Honours in Infectious Disease and Immunology from the University of Cape Town and a Management Advancement Program from the University of the Witwatersrand.
This person is not in the org chart
This person is not in any teams
This person is not in any offices